- VYNE Therapeutics (VYNE) declares $0.38/share special dividend in connection with its pending merger with Yarrow Bioscience, Inc., originally agreed upon on December 17, 2025.
- The aggregate dividend is estimated at $16.5 million, translating to approximately $0.38 per share based on 42,989,506 outstanding shares of
VYNE Therapeutics declares $0.38/share merger-contingent special dividend
